INS and metabolic disease: While it is still unclear how and from where HSP70 is released into the circulation, our study shows that the serum levels of HSP70 in men overweight without metabolic disease are significantly lower compared to men with a normal body weight and that there is a decrease in the HSP70 levels accompanied by an increase in insulin resistance.